EUVIMEDEUVIMED entdecken
Multizentrische Studie

Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion

Socorro Alforja, Adrian Hunt, Vuong Nguyen, Louise O'Toole, Pierre-Henry Gabrielle, Alessandro Invernizzi, Hemal Mehta, Theodorus Leonardus Ponsioen, David Squirrell, Ricardo P Casaroli-Marano, Daniel Barthelmes, Mark C Gillies und 2 weitere

Ophthalmology Retina · 2024

DOI: 10.1016/j.oret.2024.04.014 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2024. Verfasst von Socorro Alforja und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Univers…. Hauptthemen laut MEDLINE: Retinal Vein Occlusion, Angiogenesis Inhibitors, Intravitreal Injections, Visual Acuity. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Vein OcclusionAngiogenesis InhibitorsIntravitreal InjectionsVisual AcuityVascular Endothelial Growth Factor ARanibizumabReceptors, Vascular Endothelial Growth FactorTomography, Optical CoherenceBevacizumabHumansMaleFemaleAgedFollow-Up StudiesTreatment OutcomeRetrospective StudiesRecombinant Fusion ProteinsTime FactorsMiddle AgedMacular EdemaFluorescein AngiographyFundus Oculi

Stichwörter der Autor:innen

AfliberceptBranch retinal vein occlusionFight Retinal BlindnessRanibizumabVEGF inhibitors

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor ARanibizumabReceptors, Vascular Endothelial Growth FactorBevacizumabRecombinant Fusion Proteinsaflibercept

Autor:innen und Institutionen

  • Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain; Department of Surgery, School of…
  • Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, Australia; Department of Ophthalmology, Westmead Hospital, Westmead, Australia.
  • Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Mater Private Network, Dublin, Ireland.
  • Department of Ophthalmology, Dijon University Hospital, Dijon, France.
  • Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, Australia; Eye Clínic, Department of Biomedical and Clinical Science "L. Sacco", Luigi Sacco Hospital, University of Milan, Milan, Italy.

Zitieren

APA

Alforja, S., Hunt, A., Nguyen, V., O'Toole, L., Gabrielle, P. H., Invernizzi, A., Mehta, H., Ponsioen, T. L., Squirrell, D., Casaroli-Marano, R. P., Barthelmes, D., Gillies, M. C., Zarranz-Ventura, J., & Fight Retinal Blindness (FRB) users group (2024). Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2024.04.014

Vancouver

Alforja S, Hunt A, Nguyen V, O'Toole L, Gabrielle PH, Invernizzi A, et al. Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion. Ophthalmology Retina. 2024. doi:10.1016/j.oret.2024.04.014

BibTeX
@article{Alforja2024,
  author = {Alforja, Socorro and Hunt, Adrian and Nguyen, Vuong and O'Toole, Louise and Gabrielle, Pierre-Henry and Invernizzi, Alessandro and Mehta, Hemal and Ponsioen, Theodorus Leonardus and Squirrell, David and Casaroli-Marano, Ricardo P and Barthelmes, Daniel and Gillies, Mark C and Zarranz-Ventura, Javier and Fight Retinal Blindness (FRB) users group, Fight Retinal Blindness (FRB) users group},
  title = {Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion},
  journal = {Ophthalmology Retina},
  year = {2024},
  doi = {10.1016/j.oret.2024.04.014}
}
Kostenlos starten →